Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Codexis, Inc. - Common Stock (NQ:CDXS)

2.640 -0.100 (-3.65%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 486,194
Open 2.740
Bid (Size) 2.630 (10)
Ask (Size) 2.690 (10)
Prev. Close 2.740
Today's Range 2.590 - 2.790
52wk Range 1.900 - 6.080
Shares Outstanding 64,640,734
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Codexis Revenue Jumps 91 Percent in Q2
Via The Motley Fool

Performance

YTD
-47.2%
-47.2%
1 Month
+6.0%
+6.0%
3 Month
-8.3%
-8.3%
6 Month
+25.1%
+25.1%
1 Year
-25.0%
-25.0%

More News

Read More
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Curious about the stocks that are showing activity after the closing bell on Wednesday?
Via Chartmill
A Look at Codexis's Upcoming Earnings Report
Via Benzinga
Preview: Codexis's Earnings
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
Codexis Inc (NASDAQ:CDXS) Surpasses Q2 2025 Earnings Expectations with Strong Revenue and EPS Beat
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Get insights into the top gainers and losers of Wednesday's after-hours session.
Via Chartmill
Deep Dive Into Codexis Stock: Analyst Perspectives (4 Ratings)
Via Benzinga
Recap: Codexis Q4 Earnings
Via Benzinga
Earnings Scheduled For August 13, 2025
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
From Artiva Biotherapeutics, Inc.
Via GlobeNewswire
CDXS Stock Earnings: Codexis Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
CDXS Stock Earnings: Codexis Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Earnings Scheduled For May 14, 2025
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Codexis Clinches Deal With Nestlé Health Science, Eyes Up To $45M Milestone In EPI Treatment Breakthrough
Via Benzinga

Frequently Asked Questions

Is Codexis, Inc. - Common Stock publicly traded?
Yes, Codexis, Inc. - Common Stock is publicly traded.
What exchange does Codexis, Inc. - Common Stock trade on?
Codexis, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Codexis, Inc. - Common Stock?
The ticker symbol for Codexis, Inc. - Common Stock is CDXS on the Nasdaq Stock Market
What is the current price of Codexis, Inc. - Common Stock?
The current price of Codexis, Inc. - Common Stock is 2.640
When was Codexis, Inc. - Common Stock last traded?
The last trade of Codexis, Inc. - Common Stock was at 10/16/25 04:00 PM ET
What is the market capitalization of Codexis, Inc. - Common Stock?
The market capitalization of Codexis, Inc. - Common Stock is 170.65M
How many shares of Codexis, Inc. - Common Stock are outstanding?
Codexis, Inc. - Common Stock has 171M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.